SCHEMBL7517902

SCHEMBL7517902

Cc1ccccc1C(=O)c1ccc(Nc2ccc3c(ccn3C)c2)cc1Cl

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 13/20 0.67
MAPK13 O15264 12/20 0.67
MAPK12 P53778 12/20 0.67
MAPK11 Q15759 12/20 0.67
NOTUM Q6P988 1/20 0.49
MAOB P27338 1/20 0.47
MEN1 O00255 2/20 0.42
TP53 P04637 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
MAPT P10636 2/20 0.42
CYP2C19 P33261 2/20 0.42
HTR2B P41595 2/20 0.42
RECQL P46063 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
HTR2C P28335 3/20 0.41
PKM P14618 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7514387 0.87 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11NOTUM
SCHEMBL7514380 0.86 MAPK13 (0.48) MAPK14MAPK13MAPK12MAPK11NOTUM
SCHEMBL7513460 0.85 MAPK14 (0.46) MAPK14MAPK13MAPK12MAPK11NOTUM
SCHEMBL7510773 0.82 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL1907099 0.81 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1907736 0.80 MAPK14 (0.87) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1906787 0.77 MAPK14 (0.82) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1906735 0.77 MAPK14 (0.82) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL6656897 0.77 MAPK14 (0.82) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1907753 0.77 MAPK14 (0.82) MAPK14MAPK13MAPK12MAPK11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US claimed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA MAPK14 625/4885MAPK13 1908/4885MAPK12 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.